These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11436678)
1. [The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina]. Hamankiewicz M; Kucio C; Czapla J; Wójcik P Wiad Lek; 2001; 54(3-4):137-42. PubMed ID: 11436678 [TBL] [Abstract][Full Text] [Related]
2. [Results of international study of quality of life of patients with stable angina treated with nitrates (IQOLAN)]. Belenkov IuN; Chazova IE; Ratova LG; Dmitriev VV; Lebedeva NA; Pavlov VE; Bishele NA; Demura SA Kardiologiia; 2003; 43(9):4-7. PubMed ID: 14593363 [TBL] [Abstract][Full Text] [Related]
3. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate]. Kośmicki M; Szwed H; Kowalik I; Sadowski Z Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508 [TBL] [Abstract][Full Text] [Related]
4. Treatment of angina pectoris with isosorbide-5-mononitrate. A multicenter study in general practice. Beck EJ; Koch JE Cardiology; 1991; 79 Suppl 2():41-5. PubMed ID: 1760828 [TBL] [Abstract][Full Text] [Related]
5. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris. Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056 [TBL] [Abstract][Full Text] [Related]
6. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease. Uberbacher HJ; Steinorth G; Glocke M; Abshagen U Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis. Jansen R; Niemeyer MG; Cleophas TJ; Zwinderman AH Angiology; 2000 Dec; 51(12):1007-12. PubMed ID: 11132992 [TBL] [Abstract][Full Text] [Related]
8. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate. Parker JO Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014 [TBL] [Abstract][Full Text] [Related]
9. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584 [TBL] [Abstract][Full Text] [Related]
10. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. Bates CD; Nicoll AE; Mullen AB; Mackenzie F; Thomson AJ; Norman JE BJOG; 2003 Jan; 110(1):64-7. PubMed ID: 12504938 [TBL] [Abstract][Full Text] [Related]
11. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Thadani U Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067 [TBL] [Abstract][Full Text] [Related]
12. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina]. Demchenko EA; Berezina AV; Panov AV Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229 [No Abstract] [Full Text] [Related]
13. Isosorbide-5-mononitrate in angina pectoris. Poss M; Racicot D; Kiser WR Ann Intern Med; 1994 Oct; 121(7):547. PubMed ID: 8093205 [No Abstract] [Full Text] [Related]
14. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. Nicoll AE; Mackenzie F; Greer IA; Norman JE Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380 [TBL] [Abstract][Full Text] [Related]
16. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur? Kośmicki MA; Szwed H; Sadowski Z Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903 [TBL] [Abstract][Full Text] [Related]
17. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris]. Herrmann H; Kuhl A; Maier-Lenz H Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710 [TBL] [Abstract][Full Text] [Related]
18. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina. Akhras F; Jefferies S; Jackson G Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114 [TBL] [Abstract][Full Text] [Related]
19. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris. Chen YH; Ding PY; Wang SP Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234 [TBL] [Abstract][Full Text] [Related]
20. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group. Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]